Tiotropium Bromide Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease

Summary

A Phase 2, Randomized, Partially-blinded, Parallel Group, Dose-ranging Study to Assess the Pharmacodynamics, Relative Bioavailability, and Safety of Three Doses of Tiotropium Bromide Inhalation Solution in Subjects with Chronic Obstructive Pulmonary Disease

Timeline

Start

2020-11-01

Primary completion

2021-04-20

Completion

2021-04-26

Drugs

Indications